Mark A. Hillman Holdings Activity

Hillman Value Fund Portfolio 13F

Hillman Value Fund has disclosed a total of 19 changes to the portfolio in the latest (2023 Q4) SEC report(s): increased the number of shares of 3, bought 3 totally new, decreased the number of shares of 12 and completely sold out 1 position(s).

What stocks is Mark A. Hillman buying now?

In the recent quarter Mark A. Hillman has bought 6 securities out of which top 5 purchases (by % change to portfolio) are (EL) ESTEE LAUDER COMPANIES-CL A (new buy), (KMX) CARMAX INC (new buy), (PFE) PFIZER INC (new buy), (UMBXX) MONEY MARKET FIDUCIA (added shares +25.72%) and (JWN) NORDSTROM INC (added shares +33.3%).

What does Mark A. Hillman invest in?

Mark A. Hillman's top 5 holdings (by % of portfolio) are (UMBXX) MONEY MARKET FIDUCIA (3.9%), (SPG) SIMON PROPERTY GROUP INC (3.07%), (JWN) NORDSTROM INC (3%), (CRM) SALESFORCECOM INC (2.93%) and (BK) BANK OF NEW YORK MELLON CORP (2.91%).

In the latest report(s) the following changes have been made to the top investments: (UMBXX) MONEY MARKET FIDUCIA (added shares +25.72%) and (JWN) NORDSTROM INC (added shares +33.3%).

2023 Q1 (9 results)
UMBXX
+362.15%
+7,625,554
+3.77%
$1.00
-
4.81%
CMP
+42.31%
+44,000
+0.75%
$34.29
63.20% $12.62
2.51%
AMZN
+38.10%
+16,000
+0.82%
$103.29
68.14% $173.67
2.96%
WU
+25.85%
+84,000
+0.46%
$11.15
19.19% $13.29
2.25%
META
-22.97%
-8,200
-0.86%
$211.94
108.26% $441.38
2.88%
BA
-23.64%
-7,800
-0.82%
$212.43
21.48% $166.81
2.65%
BK
-23.78%
-33,388
-0.75%
$45.44
25.84% $57.18
2.40%
WBD
-33.05%
-178,300
-1.33%
$15.10
45.10% $8.29
2.70%
RTX
-100.00%
-55,000
-2.74%
$100.92
0.78% $101.71
0.00%
2022 Q4 (11 results)
DIS
buy
+60,000
+2.77%
$86.88
29.80% $112.77
2.77%
WBD
+50.43%
+180,866
+0.91%
$9.48
12.55% $8.29
2.72%
INTC
+15.91%
+23,000
+0.32%
$26.43
32.84% $35.11
2.35%
RTX
-15.38%
-10,000
-0.54%
$100.92
0.78% $101.71
0.00%
ZBH
-16.71%
-8,849
-0.60%
$127.50
6.08% $119.75
2.99%
T
-17.80%
-61,269
-0.60%
$18.41
9.94% $16.58
2.77%
CAG
-18.86%
-33,000
-0.68%
$38.70
19.20% $31.27
2.92%
DD
-19.72%
-18,664
-0.68%
$68.63
7.10% $73.50
2.77%
ASML
-24.13%
-2,700
-0.78%
$546.40
65.17% $902.51
2.46%
UMBXX
-70.35%
-4,996,194
-2.65%
$1.00
-
1.12%
MRK
-100.00%
-60,169
-2.75%
$86.12
51.79% $130.72
0.00%
2022 Q3 (13 results)
GSK
buy
+172,865
+2.83%
$29.43
39.01% $40.91
2.83%
TSM
buy
+67,729
+2.58%
$68.56
99.21% $136.58
2.58%
UMBXX
+125.51%
+3,952,551
+2.20%
$1.00
-
3.95%
INTC
+1.27%
+1,810
+0.03%
$25.77
36.24% $35.11
2.07%
EPD
-11.54%
-30,000
-0.40%
$23.78
21.66% $28.93
3.04%
CAG
-12.50%
-25,000
-0.45%
$32.63
4.17% $31.27
3.17%
LRCX
-12.50%
-1,800
-0.37%
$366.00
146.30% $901.47
2.56%
KHC
-22.84%
-45,000
-0.83%
$33.35
15.05% $38.37
2.82%
K
-29.09%
-32,000
-1.24%
$69.66
16.09% $58.45
3.02%
MRK
-33.15%
-29,831
-1.43%
$86.12
51.79% $130.72
0.00%
BIIB
-37.25%
-10,839
-1.61%
$267.00
24.17% $202.46
2.71%
PAA
-100.00%
-610,000
-3.33%
$9.82
84.01% $18.07
0.00%
GSK
-100.00%
-128,000
-3.87%
$54.41
24.82% $40.91
0.00%
2022 Q2 (17 results)
WBD
buy
+358,640
+2.31%
$13.42
38.23% $8.29
2.31%
LRCX
buy
+14,400
+2.94%
$426.15
111.54% $901.47
2.94%
T
+49.68%
+114,269
+1.15%
$20.96
20.90% $16.58
3.46%
BK
+27.63%
+30,388
+0.61%
$41.71
37.09% $57.18
2.81%
CRM
+24.89%
+7,615
+0.60%
$165.04
65.50% $273.14
3.02%
MSFT
+19.72%
+3,846
+0.47%
$256.83
55.37% $399.04
2.87%
WFC
+18.12%
+22,655
+0.43%
$39.17
53.00% $59.93
2.77%
INTC
+16.85%
+20,595
+0.37%
$37.41
6.15% $35.11
2.56%
META
+15.16%
+4,700
+0.36%
$161.25
173.72% $441.38
2.76%
ZBH
+12.66%
+5,949
+0.30%
$105.06
13.98% $119.75
2.67%
ASML
+11.88%
+1,188
+0.27%
$475.88
89.65% $902.51
2.55%
DD
+7.57%
+6,664
+0.18%
$55.58
32.24% $73.50
2.52%
UMBXX
-70.07%
-7,373,901
-3.54%
$1.00
-
1.51%
BMY
-100.00%
-93,000
-3.26%
$73.03
38.79% $44.70
0.00%
DISCA
-100.00%
-223,000
-2.66%
$24.92
1.97% $24.43
0.00%
ZIMV
-100.00%
-4,700
-0.05%
$22.84
32.22% $15.48
0.00%
MMP
-100.00%
-141,000
-3.32%
$49.07
40.62% $69.00
0.00%
50 of 221

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.